HLA-A and metastatic melanoma: By analysing a cohort of ICI-treated patients with metastatic melanoma, we sought to bridge the knowledge gap regarding the interplay between the HLA polymorphism HLA-A*02:01, toxicity, and therapeutic efficacy.